Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IDXG

Interpace Biosciences (IDXG) Stock Price, News & Analysis

Interpace Biosciences logo

About Interpace Biosciences Stock (NASDAQ:IDXG)

Advanced Chart

Key Stats

Today's Range
$0.83
$0.86
50-Day Range
$4.75
$10.40
52-Week Range
$2.57
$10.42
Volume
8,721 shs
Average Volume
6,816 shs
Market Capitalization
$3.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IDXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Interpace Biosciences and its competitors with MarketBeat's FREE daily newsletter.

IDXG Stock News Headlines

PDI: Credit Offers Opportunity In An Expensive Market
A new rule goes live in July — and the banks are quietly crushing it
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
PDI: Get In Before The Fed Changes The Tune
PDI: Inflection Point Ahead
PDI: Nothing Special... Yet
PDI: Huge Income, But Please Know What You Own
PDI: A Decent Income Investment
See More Headlines

IDXG Stock Analysis - Frequently Asked Questions

Interpace Biosciences, Inc. (NASDAQ:IDXG) posted its quarterly earnings results on Monday, November, 4th. The business services provider reported $0.31 EPS for the quarter. The business services provider had revenue of $12.30 million for the quarter. Interpace Biosciences had a net margin of 10.39% and a negative trailing twelve-month return on equity of 8.09%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Interpace Biosciences investors own include Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Dynavax Technologies (DVAX), Bristol Myers Squibb (BMY), Novavax (NVAX) and Histogenics (HSGX).

Company Calendar

Last Earnings
11/04/2024
Today
8/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:IDXG
CIK
1054102
Employees
152
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$800 thousand
Net Margins
10.39%
Pretax Margin
10.93%
Return on Equity
-8.09%
Return on Assets
37.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.59
Quick Ratio
0.59

Sales & Book Value

Annual Sales
$40.21 million
Price / Sales
0.09
Cash Flow
$0.43 per share
Price / Cash Flow
1.99
Book Value
($14.16) per share
Price / Book
-0.06

Miscellaneous

Outstanding Shares
4,410,000
Free Float
4,167,000
Market Cap
$3.79 million
Optionable
Not Optionable
Beta
0.76
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:IDXG) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners